Načítá se...
Expanded CD133(+) Cells from Human Umbilical Cord Blood Improved Heart Function in Rats after Severe Myocardial Infarction
Pharmacological approaches are partially effective in limiting infarct size. Cell therapies using a cell population enriched with endothelial progenitor cells (EPCs) CD133(+) have opened new perspectives for the treatment of ischemic areas after infarction. This preclinical study evaluated the effec...
Uloženo v:
| Vydáno v: | Stem Cells Int |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5925035/ https://ncbi.nlm.nih.gov/pubmed/29760727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/5412478 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|